(Q33704755)

28 July 2017

1 reference

title

Non-nicotine pharmacotherapy for smoking cessation (English)

1 reference

28 July 2017

0 references

Ferry LH

1

1 reference

28 July 2017

publication date

1 September 1999

1 reference

Primary Care: Clinics in Office Practice

28 July 2017

published in

1 reference

28 July 2017

volume

26

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

653-669

1 reference

Neural mechanisms underlying nicotine dependence

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Clinical evaluation of a citric acid inhaler for smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Nicotine dependence, major depression, and anxiety in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Nicotinic receptor blockade therapy and smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Use of beta-blocking agents with group therapy in a smoking withdrawal clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Doxepin as an adjunct to smoking cessation: a double-blind pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Doxepin in the Treatment of Nicotine Withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Mecamylamine does not precipitate withdrawal in cigarette smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Propranolol and giving up smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Buspirone reduces smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Cigarette craving, smoking withdrawal, and clonidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Is clonidine an effective smoking cessation therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Effect of Buspirone on Withdrawal Symptoms Associated With Smoking Cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Interaction of Personality and Treatment Conditions Associated with Success in a Smoking Control Program

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Effect on smoking cessation of silver acetate, nicotine and ordinary chewing gum

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

The effects of phenylpropanolamine on dietary intake, physical activity, and body weight after smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Clinical trials using ascorbic acid aerosol to aid smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Silver acetate gum as a deterrent to smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

What is the nature of mecamylamine's antagonism of the central effects of nicotine?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Effects of mecamylamine on human cigarette smoking and subjective ratings

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Effects of fluoxetine on weight gain and food intake in smokers who reduce nicotine intake

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Nicotine and the central nervous system: biobehavioral effects of cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

A critical evaluation of a lobeline based smoking deterrent

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Role of nicotine dose and sensory cues in the regulation of smoke intake

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Efficacy of buspirone in smoking cessation: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Could nicotine antagonists be used in smoking cessation?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Recycling with nicotine patches in smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

Weight gain and withdrawal symptoms after smoking cessation: a preventive intervention using d-fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970122-6

7 January 2021

10.1016/S0095-4543(05)70122-6

Identifiers

DOI

1 reference

28 July 2017

1 reference